Financial

Inari Medical to Announce Third Quarter 2024 Financial Results

Financial by Comments are Disabled

IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its third quarter 2024 financial results on Monday, October 28, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Continue Reading →

InterVene, Inc. Announces $13 Million Series A Financing to Advance Recana™ System Through US Market Clearance

Financial by 0 comments

October 07, 2024 08:00 AM Eastern Daylight Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVene, Inc., a clinical-stage medical device company dedicated to developing interventional solutions for chronic venous insufficiency (CVI), announced today the closing of its $13M Series A financing round. The financing was co-led by new investor Treo Ventures and existing […]

Continue Reading →

AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results

Financial by 0 comments

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced financial results for the first quarter of fiscal year 2025, which ended August […]

Continue Reading →

HeartX Cardiovascular Accelerator Announces Four Startup Companies Selected for the 2024 Program

Coronary/Structural Heart Financial by Comments are Disabled

BENTONVILLE, Ark., Sept. 30, 2024 /PRNewswire/ — HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices in Arkansas and around the country — has selected four startup healthcare companies to participate in its 2024 accelerator program….

Continue Reading →

Mediwhale Secures $12 Million in Series A2 Funding to Drive Global Leadership in Cardiovascular and Metabolic Disease Management

Financial by Comments are Disabled

SEOUL, South Korea, Sept. 25, 2024 /PRNewswire/ — Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for preventing…

Continue Reading →

FineHeart Appoints André-Jacques Auberton-Hervé Member of the Board of Directors

Financial by 0 comments

BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a clinical-stage medtech company developing breakthrough solutions for cardiology, is pleased to announce the appointment of André-Jacques Auberton-Hervé to its Board of Directors. “The exceptional career of André-Jacques, a visionary industrialist, is inspirational for the whole team. We sincerely thank him for the trust he has […]

Continue Reading →

HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist

Financial by 0 comments

SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, announced the appointment of Lance Myers, PhD, a pioneer in digital health data analytics and body-worn biosensor technologies, as Chief Artificial Intelligence (AI) Scientist. In this […]

Continue Reading →
1 … 69 70 71 72 73 … 489